METABONOMIC AND MICROBIOTA PROFILE OF CROHN'S PATIENTS IS A PREDICTOR OF PRIMARY NON-RESPONSE TO ANTI-TNF THERAPY

(1) University of Melbourne,Medicine,Melbourne,Australia

(2) Imperial College,Centre for Computational and Systems Medicine,London,United Kingdom

(3) Imperial College,Centre for Computational Systems Medicine,London,United Kingdom

(4) St. Marks Hospital,Gastroenterology,London,United Kingdom

(5) St. Mark's Hospital,IBD Unit,Harrow,United Kingdom

(6) Imperial College London,Division of Computational and Systems Medicine. Department of Surgery and Cancer.,London,United Kingdom

(7) St Mark’s Hospital and Academic Institue,Gastroenterology,London,United Kingdom



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)